Onicoma 0.1 is a Product of the Generic Efinaconazole

Onicoma 0.1 belongs to the generic category of Efinaconazole. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Onicoma 0.1. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Efinaconazole and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Onicoma 0.1

Onicoma 0.1 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Onicoma 0.1 is provided below to help users gain a clear understanding of this medicine.

What Is Onicoma 0.1 Indications and Uses?

Efinaconazole Topical Solution is indicated for the treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.

Pharmacology (Source, Chemical and Physical Composition) Of Onicoma 0.1

Efinaconazole is an azole antifungal. It inhibits fungal lanosterol 14α-demethylase involved in thebiosynthesis of ergosterol, a constituent of fungal cell membranes.

Dosage And Administration of Onicoma 0.1

Route of administration: Efinaconazole is for topical use only.Apply this solution to affected toenails once daily for 48 weeks, using theintegrated flow-through brush applicator. When applying it, ensure the toenail, the toenail folds, toenail bed, hyponychium, and the undersurface of the toenail plate, are completely covered.Use in children and adolescents: Safety and effectiveness of efinaconazole solution in pediatric patients under 6 years of age have not been established.

Drug Interactions of Onicoma 0.1

Drug interaction with medication: This solution, at therapeutic concentrations, neither inhibits nor induces cytochrome P450 (CYP450) enzymes.

Side Effects of Onicoma 0.1

The most common side effects are ingrown toenails, application site dermatitis, application site vesicles and application site pain.

Use During Pregnancy and Lactation

There are no available human data for the use of this solution during pregnancy to inform any drug associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes. It is not known whether efinaconazole is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this solution is administered to nursing women.

Precautions And Warnings for Onicoma 0.1

Efinaconazole is for topical use only and not for oral, ophthalmic or intravaginal use. If the area of application shows signs of persistent irritation (for example, redness, itching, swelling), stop the use of this solution. This solution is flammable, avoid use near heat or open flame.

Storage Conditions of It

Store in a cool (below 30ºC) & dry place protected from light. Keep out of the reach of children.

Onicoma 0.1 is a Product of the Generic Efinaconazole

Onicoma 0.1

ACI Limited · Topical Solution

Efinaconazole